Adeshwar Meditex Board of Directors

Get the latest insights into the leadership at Adeshwar Meditex. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Ms. Ashalata Baburao Raut Chairman & Wholetime Director
Mr. Krishnojirao Nagaraja Rao Whole Time Director
Mr. Abhinandan Nagaraja Rao Additional & Executive Director
Mr. Shailesh Vinayak Rajpure Director
Mr. Benegal Parameshwara Udpa Ind. Non-Executive Director
Mr. Arun Koli Ind. Non-Executive Director
Mr. Prithvi Sanjay Singh Non Executive Director

Adeshwar Meditex Share price

ADESHWAR

17.99

0.00 (0.00%)
Last updated on 4 Sep, 2025 | 16:00 IST
BUYSELL
Today's High

00

Today's Low

00

52 Week Low

15.00

52 Week High

26.50

The current prices are delayed, login to your account for live prices

Adeshwar Meditex FAQs

The board at Adeshwar Meditex consists of experienced professionals, including Ms. Ashalata Baburao Raut , Mr. Krishnojirao Nagaraja Rao , and others, overseeing the company’s strategic and corporate governance.

Directors at Adeshwar Meditex are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Ms. Ashalata Baburao Raut is the current chairman at Adeshwar Meditex.

Executive directors at Adeshwar Meditex are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Adeshwar Meditex adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Adeshwar Meditex, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.